Immune dysfunction possibly linked to schizophrenia

October 19, 2012
Immune dysfunction possibly linked to schizophrenia
Credit: Shutterstock

Schizophrenia is a complex illness; among other characteristics, sufferers often find it difficult to tell the difference between what is real and not real and have trouble thinking clearly. Its symptoms could develop over months or years and mental health experts are still not entirely sure what causes it, though it is suspected that genes play a role.

A new study has discovered that a region of the genome involved in , called the major histocompatibility complex (MHC), is involved in the to schizophrenia.

Approximately seven in every thousand in the are affected by schizophrenia which is among the most disabling . It is estimated that 80 per cent of the risk for developing schizophrenia is heritable, but there has been slow progress in identifying that contributes to the risk for schizophrenia.

Two internationally renowned groups of scientists - the Wellcome Trust Case Control Consortium 2 and the Irish Schizophrenia Genomics Consortium - collaborated for this new study. It contributes to a growing literature by identifying variants of genes that influence the function of the immune system which may contribute to the heritable risk for schizophrenia.

Their findings, which were based on multiple datasets and approaches, lend further support for the involvement of the in . 'In this large collaborative effort, we have replicated evidence for specific risk and protective at the MHC locus - a critical step teasing apart the mechanisms involved,' commented Dr Aiden Corvin, one of the lead authors and a professor at Trinity College Dublin. 'However, pinpointing specific risk genes or alleles has been challenging because this is a region of great genomic variation within and between populations.'

The researchers began their work by conducting a discovery scan. They analysed over 6 million genetic variants in schizophrenia patients and controls from Ireland. This allowed them to compile a list of variants that showed the strongest association signals with schizophrenia.

They then performed similar work in an independent sample of 13,195 cases and 31,021 controls from around the world to look for the same top 'hits'. This wealth of data was provided by the international schizophrenia genetics community. The replication work is an important scientific strategy, particularly in the field of genetics, to strengthen and support the original findings.

The team's genetic findings also highlight an important gap in understanding of the biology of schizophrenia. There is a long history of interest in immunologic contribution to schizophrenia, including wide ranging observations linking viral infection, gluten sensitivity, changes in cytokine levels in blood and cerebrospinal fluid, and other factors to schizophrenia.

'Despite this, we have relatively little understanding how alterations in immune function are involved in the etiology and pathophysiology of this disorder,' commented Dr John Krystal, Editor of Biological Psychiatry. 'Immunologic studies in schizophrenia that illuminate the nature of the contribution of variation in immune system genes to schizophrenia will be an important new direction in schizophrenia research.'

Explore further: Does immune dysfunction contribute to schizophrenia?

Related Stories

Does immune dysfunction contribute to schizophrenia?

October 10, 2012
A new study reinforces the finding that a region of the genome involved in immune system function, called the major histocompatibility complex (MHC), is involved in the genetic susceptibility to schizophrenia.

Replicating risk genes in bipolar disorder

October 15, 2012
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies.

A gene implicated in schizophrenia risk is also associated with risk for cannabis dependence

October 11, 2012
A paper by Shizhong Han and colleagues in the current issue of Biological Psychiatry implicates a new gene in the risk for cannabis dependence. This gene, NRG1, codes for the ErbB4 receptor, a protein implicated in synaptic ...

Large study finds genetic 'overlap' between schizophrenia, bipolar disorder

September 21, 2011
Knowledge about the biological origin of diseases like schizophrenia, bipolar disorder and other psychiatric conditions is critical to improving diagnosis and treatment.

Recommended for you

Before assigning responsibility, our minds simulate alternative outcomes, study shows

October 17, 2017
How do people assign a cause to events they witness? Some philosophers have suggested that people determine responsibility for a particular outcome by imagining what would have happened if a suspected cause had not intervened.

For older adults, volunteering could improve brain function

October 17, 2017
Older adults worried about losing their cognitive functions could consider volunteering as a potential boost, according to a University of Missouri researcher. While volunteering and its associations with physical health ...

Magic mushrooms may 'reset' the brains of depressed patients

October 13, 2017
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

Living near a forest keeps your amygdala healthier

October 13, 2017
A study conducted at the Max Planck Institute for Human Development has investigated the relationship between the availability of nature near city dwellers' homes and their brain health. Its findings are relevant for urban ...

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

Researchers find a fine timeline between delusion and reality

October 12, 2017
The line between reality and delusion may be just a matter of time, a new Yale study suggests.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Argiod
1 / 5 (1) Oct 20, 2012
"A new study has discovered that a region of the genome involved in immune system function, called the major histocompatibility complex (MHC), is involved in the genetic susceptibility to schizophrenia."

This suggests that paranoia is related to or may be a psychotropic allergy. Instead of developing a rash, you wind up with personality shifts.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.